JP2008538109A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538109A5
JP2008538109A5 JP2008502895A JP2008502895A JP2008538109A5 JP 2008538109 A5 JP2008538109 A5 JP 2008538109A5 JP 2008502895 A JP2008502895 A JP 2008502895A JP 2008502895 A JP2008502895 A JP 2008502895A JP 2008538109 A5 JP2008538109 A5 JP 2008538109A5
Authority
JP
Japan
Prior art keywords
fluoro
alkyl
phenyl
methanesulfonylamino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008502895A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538109A (ja
JP5159604B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2006/000929 external-priority patent/WO2006101318A1/en
Publication of JP2008538109A publication Critical patent/JP2008538109A/ja
Publication of JP2008538109A5 publication Critical patent/JP2008538109A5/ja
Application granted granted Critical
Publication of JP5159604B2 publication Critical patent/JP5159604B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008502895A 2005-03-19 2006-03-15 バニロイド受容体拮抗薬としての新規な化合物、その異性体又はその薬剤学的に許容される塩、及びこれを含む医薬組成物 Expired - Fee Related JP5159604B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2005-0022986 2005-03-19
KR20050022986 2005-03-19
US66326905P 2005-03-21 2005-03-21
US60/663,269 2005-03-21
PCT/KR2006/000929 WO2006101318A1 (en) 2005-03-19 2006-03-15 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

Publications (3)

Publication Number Publication Date
JP2008538109A JP2008538109A (ja) 2008-10-09
JP2008538109A5 true JP2008538109A5 (https=) 2009-04-09
JP5159604B2 JP5159604B2 (ja) 2013-03-06

Family

ID=37023953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008502895A Expired - Fee Related JP5159604B2 (ja) 2005-03-19 2006-03-15 バニロイド受容体拮抗薬としての新規な化合物、その異性体又はその薬剤学的に許容される塩、及びこれを含む医薬組成物
JP2008502896A Expired - Fee Related JP5064374B2 (ja) 2005-03-19 2006-03-17 バニロイド受容体拮抗薬としての新規な化合物、その異性体またはその薬剤学的に許容される塩、及びこれを含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008502896A Expired - Fee Related JP5064374B2 (ja) 2005-03-19 2006-03-17 バニロイド受容体拮抗薬としての新規な化合物、その異性体またはその薬剤学的に許容される塩、及びこれを含む医薬組成物

Country Status (14)

Country Link
US (2) US7763657B2 (https=)
EP (2) EP1861357B1 (https=)
JP (2) JP5159604B2 (https=)
KR (2) KR101304981B1 (https=)
AR (2) AR053561A1 (https=)
AU (2) AU2006225496A1 (https=)
BR (2) BRPI0608714A2 (https=)
CA (2) CA2601871A1 (https=)
EA (2) EA200702020A1 (https=)
IL (2) IL185891A0 (https=)
MX (2) MX2007011466A (https=)
NO (2) NO20075353L (https=)
TW (2) TW200716523A (https=)
WO (2) WO2006101318A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101304981B1 (ko) * 2005-03-19 2013-09-06 (주)아모레퍼시픽 바닐로이드 수용체 길항물질로서의 신규 화합물, 이의이성체 또는 이의 약학적으로 허용가능한 염, 및 이를함유하는 약학 조성물
PL2054411T3 (pl) 2006-07-27 2015-02-27 Amorepacific Corp Nowe związki, ich izomery lub ich farmaceutycznie dopuszczalne sole jako antagoniści receptora waniloidowego oraz zawierające je kompozycje farmaceutyczne
DE102007017884A1 (de) 2007-04-13 2008-10-16 Grünethal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
US20110160279A1 (en) * 2007-08-13 2011-06-30 Board Of Trustees Of Southern Illinois University METHODS FOR TREATMENT AND PREVENTION OF OTOTOXICITY BY siRNA
US8557872B2 (en) 2008-01-28 2013-10-15 Amorepacific Corporation Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
WO2009136625A1 (ja) * 2008-05-07 2009-11-12 大日本住友製薬株式会社 環状アミン-1-カルボン酸エステル誘導体およびそれを含有する医薬組成物
US8691855B2 (en) 2008-07-02 2014-04-08 Amorepacific Corporation Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
CN103429242A (zh) * 2010-11-03 2013-12-04 夏威夷大学 用于预防和治疗心脏肥大的方法和组合物
AR085509A1 (es) 2011-03-09 2013-10-09 Bayer Cropscience Ag Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
ES2643403T3 (es) 2011-12-28 2017-11-22 Global Blood Therapeutics, Inc. Compuestos de benzaldehído sustituidos y métodos para su uso en el aumento de la oxigenación tisular
HK1203412A1 (en) 2011-12-28 2015-10-30 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
HK1214587A1 (en) * 2012-12-28 2016-07-29 Nippon Zoki Pharmaceutical Co., Ltd. Cinnamamide derivative
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN105073728A (zh) 2013-03-15 2015-11-18 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
WO2014150258A1 (en) 2013-03-15 2014-09-25 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MX379235B (es) 2013-03-15 2025-03-11 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina.
CN114181195A (zh) 2014-02-07 2022-03-15 全球血液疗法股份有限公司 一种化合物的结晶多晶型物
SG11201804647TA (en) 2015-12-04 2018-06-28 Global Blood Therapeutics Inc Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087254A (ja) * 1983-10-19 1985-05-16 Japan Carlit Co Ltd:The 新規尿素化合物及びそれを含有する除草剤
HK1042472B (zh) * 1999-02-22 2005-12-09 Medifron Dbt Co., Ltd. 作爲有效的香草类受体激动剂和镇痛药的含有树脂毒素药效基团的香草类类似物,其组合物以及应用
ATE328868T1 (de) 2000-08-21 2006-06-15 Pacific Corp Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten
AU2001280229B2 (en) 2000-08-21 2006-12-07 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
GB0105895D0 (en) * 2001-03-09 2001-04-25 Smithkline Beecham Plc Novel compounds
MXPA04005427A (es) 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
BR0309940A (pt) * 2002-05-08 2005-02-09 Bayer Healthcare Ag Derivados de hidróxi-tetraidro-naftaleniluréia
AU2003251828A1 (en) * 2002-07-12 2004-02-02 Janssen Pharmaceutica N.V. Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
KR101042490B1 (ko) * 2004-07-15 2011-06-16 니뽄 다바코 산교 가부시키가이샤 축합 벤즈아미드 화합물 및 바닐로이드 수용체 1형(vr1)활성 저해제
ITMI20042042A1 (it) * 2004-10-26 2005-01-26 Pharmeste Srl Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1
ES2331153T3 (es) * 2005-03-10 2009-12-22 Pfizer Inc. Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos.
KR101304981B1 (ko) 2005-03-19 2013-09-06 (주)아모레퍼시픽 바닐로이드 수용체 길항물질로서의 신규 화합물, 이의이성체 또는 이의 약학적으로 허용가능한 염, 및 이를함유하는 약학 조성물

Similar Documents

Publication Publication Date Title
JP2008538109A5 (https=)
JP4850702B2 (ja) 優秀な鎮痛作用を示すバニロイドアンタゴニストとしての4−(メチルスルホニルアミノ)フェニルアナログおよびこれを含む医薬組成物
AU2007277519B2 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
RU2009119290A (ru) Производные гидантоина, используемые в качестве ингибиторов ммр
RU2011101951A (ru) Способ получения стимулятора апоптоза авт-263
JP2008505874A5 (https=)
CA2667285A1 (en) New sulfonamide derivatives as bradykinin antagonists
CZ315196A3 (en) Sulfonamide derivatives and pharmaceutical composition containing thereof
CA2577220A1 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
US20030207939A1 (en) Novel 3-substituted urea derivatives and medicinal use thereof
JP2010522197A5 (https=)
AU2020257561B2 (en) N-acyl-{4-((4-aryl-phenyl)sulfonylmethyl)piperidine} compounds and their therapeutic use
JP2008537547A5 (https=)
CA2667481A1 (en) New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
JP2004503534A (ja) 15−リポキシゲナーゼの阻害剤としての1,2,4−三置換ベンゼン
JP5159604B2 (ja) バニロイド受容体拮抗薬としての新規な化合物、その異性体又はその薬剤学的に許容される塩、及びこれを含む医薬組成物
CN1124486A (zh) 含有杂环基团的脒衍生物及其制备和应用
RU2008149936A (ru) (2r)-2-[(4-сульфонил)аминофенил]пропанамиды и содержащие их фармацевтические композиции
JP2013509376A5 (https=)
CA2587149A1 (en) Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds
JP2004534772A (ja) アミノアルコール誘導体
JP2005518363A5 (https=)
JP2013503170A5 (https=)
JP2018529703A5 (https=)
JP2007536322A5 (https=)